Literature DB >> 33645266

Locally advanced tongue squamous cell carcinoma in epidermolysis simplex bullosa patient: a therapeutic conundrum.

W Al Shareef1, S Sayed1, S Kamel1, H Alkaf1, A Bahaj1, R Amin1, A Al Herabi1.   

Abstract

Epidermolysis bullosa simplex (EBS) is a debilitating condition affecting the skin and mucous membranes that is characterised by frequent ulceration and blistering on trivial trauma. In EBS, oral cavity mucosal injuries lead to a high propensity for developing squamous cell carcinomas. Locally advanced tongue carcinoma arising in this background presents a challenging therapeutic conundrum. To our knowledge, this is the first case of aggressive locally advanced tongue carcinoma that has developed sporadically in a patient with EBS and no family history. Routine screening of oral mucosal lesions will lead to early detection and timely management of this debilitating condition.

Entities:  

Keywords:  Epidermolysis bullosa; Epidermolysis simplex bullosa; Oral cancer; Squamous cell carcinoma; Tongue cancer

Mesh:

Year:  2021        PMID: 33645266      PMCID: PMC9158067          DOI: 10.1308/rcsann.2020.7080

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.951


  6 in total

1.  A novel homozygous keratin 14 mutation in a patient with autosomal recessive epidermolysis bullosa simplex and squamous cell carcinoma of the tongue.

Authors:  J O Baek; H Y Lee; S W Oh; J S Lee; S C Kim; J R Lee; J Y Roh
Journal:  Br J Dermatol       Date:  2010-01-21       Impact factor: 9.302

2.  Treatment of dystrophic epidermolysis bullosa with bone marrow non-hematopoeitic stem cells: a randomized controlled trial.

Authors:  Mohammad El-Darouti; Marwa Fawzy; Iman Amin; Rania Abdel Hay; Rehab Hegazy; Hala Gabr; Zeinab El Maadawi
Journal:  Dermatol Ther       Date:  2015-10-05       Impact factor: 2.851

Review 3.  Radiation therapy for squamous cell carcinoma in dystrophic epidermolysis bullosa: case reports and literature review.

Authors:  K T Bastin; R A Steeves; M J Richards
Journal:  Am J Clin Oncol       Date:  1997-02       Impact factor: 2.339

4.  Phase II study of single-agent panitumumab in patients with incurable cutaneous squamous cell carcinoma.

Authors:  M C Foote; M McGrath; A Guminski; B G M Hughes; J Meakin; D Thomson; D Zarate; F Simpson; S V Porceddu
Journal:  Ann Oncol       Date:  2014-08-04       Impact factor: 32.976

Review 5.  Management of cutaneous squamous cell carcinoma in patients with epidermolysis bullosa: best clinical practice guidelines.

Authors:  J E Mellerio; S J Robertson; C Bernardis; A Diem; J D Fine; R George; D Goldberg; G B Halmos; M Harries; M F Jonkman; A Lucky; A E Martinez; E Maubec; S Morris; D F Murrell; F Palisson; E I Pillay; A Robson; J C Salas-Alanis; J A McGrath
Journal:  Br J Dermatol       Date:  2015-11-07       Impact factor: 9.302

Review 6.  Inherited epidermolysis bullosa and squamous cell carcinoma: a systematic review of 117 cases.

Authors:  H Montaudié; C Chiaverini; E Sbidian; A Charlesworth; J-P Lacour
Journal:  Orphanet J Rare Dis       Date:  2016-08-20       Impact factor: 4.123

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.